We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$441M
AUM Growth
-$7.2M
Cap. Flow
-$15.4M
Cap. Flow %
-3.5%
Top 10 Hldgs %
34.06%
Holding
77
New
16
Increased
19
Reduced
16
Closed
21

Top Buys

Rank Stock Value
1
TRU icon
TransUnion
TRU
+$9.23M
2
IQV icon
IQVIA
IQV
+$8.98M
3
ACN icon
Accenture
ACN
+$8.87M
4
NFLX icon
Netflix
NFLX
+$8.8M
5
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
+$8.72M

Top Sells

Rank Stock Value
1
WBC
WABCO HOLDINGS INC.
WBC
+$15.9M
2
ATRA icon
Atara Biotherapeutics
ATRA
+$10.9M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
EQT icon
EQT Corp
EQT
+$9.38M
5
OTEX icon
Open Text
OTEX
+$8.46M

Sector Composition

Rank Sector Weight
1 Financials 20.75%
2 Healthcare 16.38%
3 Technology 15.02%
4 Communication Services 12.02%
5 Consumer Discretionary 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
51
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.54M 0.8%
+20,505
New +$3.55M
ASND icon
52
Ascendis Pharma A/S
ASND
$16.8B
$3.47M 0.79%
30,134
-6,479
-18% -$775K
QVCGA
53
DELISTED
QVC Group Inc Series A
QVCGA
$3.2M 0.73%
5,318
– –
RYTM icon
54
Rhythm Pharmaceuticals
RYTM
$8.1B
$3.05M 0.69%
+138,697
New +$3.5M
CBAY
55
DELISTED
Cymabay Therapeutics
CBAY
$2.04M 0.46%
+285,301
New +$3.23M
BCRX icon
56
BioCryst Pharmaceuticals
BCRX
$2.71B
$1.85M 0.42%
+489,196
New +$2.94M
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$30B
– –
-31,101
Closed -$2.91M
ATRA icon
58
Atara Biotherapeutics
ATRA
$83.1M
– –
-10,969
Closed -$10.9M
BLK icon
59
Blackrock
BLK
$180B
– –
-19,440
Closed -$8.31M
EQT icon
60
EQT Corp
EQT
$33.8B
– –
-452,228
Closed -$9.38M
ICE icon
61
Intercontinental Exchange
ICE
$85B
– –
-108,368
Closed -$8.25M
INSM icon
62
Insmed
INSM
$28.9B
– –
-98,939
Closed -$2.88M
IRWD icon
63
Ironwood Pharmaceuticals
IRWD
$714M
– –
-221,500
Closed -$2.51M
JBGS
64
JBG SMITH
JBGS
$691M
– –
-203,073
Closed -$8.4M
META icon
65
Meta Platforms (Facebook)
META
$1.47T
– –
-50,201
Closed -$8.37M
NKTR icon
66
Nektar Therapeutics
NKTR
$2.57B
– –
-4,039
Closed -$2.04M
OTEX icon
67
Open Text
OTEX
$5.8B
– –
-220,009
Closed -$8.46M
RCKT icon
68
Rocket Pharmaceuticals
RCKT
$374M
– –
-171,015
Closed -$3M
SAGE
69
DELISTED
Sage Therapeutics
SAGE
– –
-16,334
Closed -$2.6M
STAA icon
70
STAAR Surgical
STAA
$1.27B
– –
-73,424
Closed -$2.51M
UTHR icon
71
United Therapeutics
UTHR
$21.9B
– –
-21,784
Closed -$2.56M
VNDA icon
72
Vanda Pharmaceuticals
VNDA
$314M
– –
-128,346
Closed -$2.36M
ONC
73
BeOne Medicines Ltd
ONC
$40.6B
– –
-19,173
Closed -$2.53M
ABMD
74
DELISTED
Abiomed Inc
ABMD
– –
-7,216
Closed -$2.06M
CLVS
75
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-101,386
Closed -$2.52M
1 2
3
4

Similar funds

PPL
PATRIZIA Pty Ltd Barton, Australia $67.3M AUM 26.18% 1-Year Est. Return
ACH
Avista Capital Holdings New York $68.4M AUM 23% 1-Year Est. Return
TM
Titan Managers Scottsdale, Arizona $63.6M AUM 0.03% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
DLDF
Dan L. Duncan Foundation Houston, Texas $70.6M AUM 22.88% 1-Year Est. Return
AGFIA
Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return
ARC
Arias Resource Capital George Town, Grand Cayman, Cayman Islands $58.6M AUM 26.15% 1-Year Est. Return
ST
SAL Trading Bala Cynwyd, Pennsylvania $57M AUM 33.89% 1-Year Est. Return

University of Notre Dame du Lac's Q2 2019 Portfolio in Review

As of Q2 2019, University of Notre Dame du Lac held 77 positions worth $441M, down 1.6% from $448M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

University of Notre Dame du Lac withdrew a net $15.4M in Q2 2019, closing 21 positions and reducing 16 holdings. Its most notable exit was WABCO HOLDINGS INC., an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

Against the trend, University of Notre Dame du Lac opened a new position in TransUnion worth $9.92M.

  • University of Notre Dame du Lac's largest Q2 2019 buy was TransUnion: 134,902 shares worth $9.92M.
  • University of Notre Dame du Lac added most to GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2019, an estimated $8.72M increase.
  • University of Notre Dame du Lac's biggest Q2 2019 reduction was Microsoft, cutting an estimated $10.8M.
  • University of Notre Dame du Lac fully exited WABCO HOLDINGS INC. in Q2 2019, selling an estimated $15.9M.
  • University of Notre Dame du Lac's ten largest holdings make up 34% of its $441M portfolio in Q2 2019.
  • University of Notre Dame du Lac opened 16 new positions and closed 21 in Q2 2019.
  • University of Notre Dame du Lac's portfolio value fell 1.6% quarter-over-quarter to $441M.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.